Vaccinia Virus Expression System

The vaccinia virus expression system consists of genetically modified (recombinant) vaccinia viruses and vertebrate host cells; it allows transfer and expression of foreign (nonvaccinia) genes into the cytoplasm of infected animal cells.

Keywords: Vaccinia virus; gene expression; immunization; vaccination

Figure 1. Construction of a recombinant vaccinia virus by homologous recombination. In a first step, a eukaryotic host cell is infected with a wild-type vaccinia virus. Next, the plasmid transfer vector is transfected into the cells. This vector usually provides the foreign cDNA (ORF) controlled by a vaccinia promoter (P) and a selection marker (S) flanked by viral sequences (FL, left flank; FR, right flank). The recombinant virus is generated in vivo in the cytoplasm of the host cell. The flanking virus DNA on the plasmid vector directs the foreign gene cassette into the homologous site in the virus genome. Virus assembly results in infectious recombinant virus, which is released by budding into the extracellular space. Plaque purifications, usually under selective conditions, allow the isolation of pure recombinant viruses.
Figure 2. Identification of recombinant viruses by selection and staining techniques. (a) Viruses containing, for instance, a gpt selection marker are plated on to indicator cells under selective conditions in low melting agarose. After 2 days, viral plaques are visualized by staining the indicator cells with a second agarose overlay containing neutral red. (b) Wild-type viruses grown under the same conditions form minute plaques that are not visible by neutral red staining. (c) A recombinant virus with a lacZ marker gene can be identified by addition of the chromogenic substrate X-Gal to the neutral red overlay; local -galactosidase expression results in blue plaques.
Figure 3. Nonreplicating vaccinia viruses growing in complementing cell lines. A permanent cell line expressing a vaccinia gene essential for viral multiplication (complementing host cell) permits the construction and propagation of recombinant vaccinia viruses lacking the essential gene (recombinant defective vaccinia virus). The design of the plasmid transfer vector may be chosen so that a desired foreign gene substitutes the viral essential gene. The recombinant defective viruses still infect normal hosts (cells or animals), and produce viral proteins including the recombinant antigens, but do not multiply and spread. Multiplication of the virus is limited to an engineered complementing host cell line.
close
 References
    Antoine G, Scheiflinger F, Dorner F and Falkner FG (1998) The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244: 365–396.
    Bennink JR, Yewdell JW, Smith GL, Moller C and Moss B (1984) Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells. Nature 311: 578–579.
    Domi A and Moss B (2002) Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells. Proceedings of the National Academy of Sciences of the USA 99: 12415–12420.
    Drexler I, Staib C, Kastenmuller W et al. (2003) Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines. Proceedings of the National Academy of Sciences of the USA 100: 217–222.
    Holzer GW and Falkner FG (1997) Construction of a vaccinia virus deficient in the essential DNA repair enzyme uracil DNA glycosylase by a complementing cell line. Journal of Virology 71: 4997–5002.
    Kieny MP, Lathe R, Drillien R et al. (1984) Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature 312: 163–166.
    Konetschny C, Holzer GW, Urban C et al. (2003) Generation of transduction-competent retroviral vectors by infection with a single hybrid vaccinia virus. Journal of Virology 77: 7017–7025.
    Mackett M, Smith GL and Moss B (1982) Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proceedings of the National Academy of Sciences of the USA 79: 7415–7419.
    Mulryan K, Ryan MG, Myers KA et al. (2002) Attenuated recombinant vaccinia virus expressing oncofetal antigen (tumor-associated antigen) 5T4 induces active therapy of established tumors. Molecular Cancer Therapy 1: 1129–1137.
    Panicali D and Paoletti E (1982) Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proceedings of the National Academy of Sciences of the USA 79: 4927–4931.
    Ramshaw IA and Ramsay AJ (2000) The prime–boost strategy: exciting prospects for improved vaccination. Immunology Today 21: 163–165.
    Sutter G, Wyatt LS, Foley PL, Bennink JR and Moss B (1994) A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus. Vaccine 12: 1032–1040.
 Further Reading
    Moss B (1996) Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proceedings of the National Academy of Sciences of the USA 93: 11341–11348.
    Paoletti E (1996) Applications of pox virus vectors to vaccination: an update. Proceedings of the National Academy of Sciences of the USA 93: 11349–11353.
    Smith GL, Symons JA, Khanna A, Vanderplasschen A and Alcami A (1997) Vaccinia virus immune evasion. Immunological Reviews 159: 137–154.
    ePath PBR Consortium (2005) Poxvirus Bioinf ormatics Resource Center http://www.poxvirus.org/ The Poxvirus Bioinformatics Resource Center provides resources (relational database that supports data storage of poxvirus genomic sequences, etc.) to the scientific community.
Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Falkner, Falko G, and Dorner, Friedrich(Sep 2005) Vaccinia Virus Expression System. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1038/npg.els.0003859]